Caveolin family proteins, including caveolin-1 (Cav-1), caveolin-2 (Cav-2), and caveolin-3 (Cav-3), are identified as the principal protein components of caveolae in mammalian cells. Circulating form of caveolin family proteins can be used as a good potential biomarker for predicting disease.
Methods
To investigate the clinical significance of the serological levels of caveolin family proteins in patients with systemic lupus erythematosus (SLE), we evaluated the soluble serum levels of caveolin family proteins in patients with SLE by enzyme-linked immunosorbent assay (ELISA) and assessed their associations with various known clinical variables.
Results
The major findings of our study are as follows: Cav-2 was not detected in serum of SLE patients and normal controls (NCs). Serum Cav-1 and Cav-3 levels were higher in SLE patients compared with NCs. There were no significant correlations between serum Cav-1 and Cav-3 levels and SLE disease activity. Further analysis showed that serum Cav-3 may be more valuable as a marker than serum Cav-1 in SLE patients.
Conclusion
Serum levels of Cav-1 and Cav-3 might have a diagnostic role in patients with SLE. However, their predictive and prognostic value was not determined. Further studies are necessary to determine the potential clinical significance of these assays in SLE.
PicardMWallaceDCBurelleY. The rise of mitochondria in medicine. Mitochondrion2016; 30: 105–116.
2.
RothbergKGHeuserJEDonzellWC, et al. Caveolin, a protein component of caveolae membrane coats. Cell1992; 68(4): 673–682.
3.
SchererPEOkamotoTChunM, et al. Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. Proc Natl Acad Sci USA1996; 93(1): 131–135.
4.
WayMPartonRG. M-caveolin, a muscle-specific caveolin-related protein. FEBS Lett1996; 378(1): 108–112.
5.
TangZSchererPEOkamotoT, et al.Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem1996; 271(4): 2255–2261.
6.
HnaskoRLisantiMP. The biology of caveolae: lessons from caveolin knockout mice and implications for human disease. Mol Interv2003; 3(8): 445–464.
7.
CaoGYangGTimmeTL, et al.Disruption of the caveolin-1 gene impairs renal calcium reabsorption and leads to hypercalciuria and urolithiasis. Am J Pathol2003; 162(4): 1241–1248.
8.
WoodmanSECheungMWTarrM, et al.Urogenital alterations in aged male caveolin-1 knockout mice. J Urol2004; 171(2 Pt 1): 950–957.
9.
Del GaldoFLisantiMPJimenezSA. Caveolin-1, transforming growth factor-beta receptor internalization, and the pathogenesis of systemic sclerosis. Curr Opin Rheumatol2008; 20(6): 713–719.
10.
Del GaldoFSotgiaFde AlmeidaCJ, et al.Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis. Arthritis Rheum2008; 58(9): 2854–2865.
11.
Castello-CrosRWhitaker-MenezesDMolchanskyA, et al.Scleroderma-like properties of skin from caveolin-1-deficient mice: implications for new treatment strategies in patients with fibrosis and systemic sclerosis. Cell Cycle2011; 10(13): 2140–2150.
12.
RazaniBWangXBEngelmanJA, et al.Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae. Mol Cell Biol2002; 22(7): 2329–2344.
13.
GalbiatiFEngelmanJAVolonteD, et al.Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities. J Biol Chem2001; 276(24): 21425–21433.
14.
HagiwaraYSasaokaTAraishiK, et al.Caveolin-3 deficiency causes muscle degeneration in mice. Hum Mol Genet2000; 9(20): 3047–3054.
15.
LiuJMChengSHLiuXX, et al. Prognostic value of caveolin-1 in genitourinary cancer: a meta-analysis. Int J Clin Exp Med2015; 8(11): 20760–20768.
16.
LogozziMDe MilitoALuginiL, et al. High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS One2009; 4(4): e5219.
17.
SugieSMukaiSTsukinoH, et al. Increased plasma caveolin-1 levels are associated with progression of prostate cancer among Japanese men. Anticancer Res2013; 33: 1893–1897.
18.
LinCJYunEJLoUG, et al. The paracrine induction of prostate cancer progression by caveolin-1. Cell Death Dis2019; 10(11): 834.
19.
TahirSARenCTimmeTL, et al. Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer. Clin Cancer Res2003; 9: 3653–3659.
20.
TahirSAFrolovAHayesTG, et al. Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohort. Clin Cancer Res2006; 12(16): 4872–4875.
21.
TasFKarabulutSTilgen YasaseverC, et al. Clinical significance of serum caveolin-1 levels in melanoma patients. Int J Dermatol2016; 55(5): 558–562.
22.
TasFKarabulutSErturkK, et al. Clinical significance of serum caveolin-1 levels in gastric cancer patients. Exp Oncol2018; 40(4): 323–327.
23.
ErdemliHKKocabasRSalisO, et al. Is serum caveolin-1 a useful biomarker for progression in patients with colorectal cancer?Clin Lab2016; 62(3): 401–408.
24.
YilmazNOlgunSAhiskaliR, et al. Decreased sputum caveolin-1 is associated with systemic sclerosis related lung disease. Sarcoidosis Vasc Diffuse Lung Dis2014; 31(1): 55–61.
25.
SunLYQuXChenLZ, et al. Potential roles of serum caveolin-3 levels in patients with atrial fibrillation. Front Aging Neurosci2017; 9: 90.
26.
HochbergMC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1997; 40(9): 1725.
VolonteDGalbiatiF. Caveolin-1, a master regulator of cellular senescence. Cancer Metastasis Rev2020; 39(2): 397–414.
29.
FilippiniAD'AlessioA. Caveolae and lipid rafts in endothelium: valuable organelles for multiple functions. Biomolecules2020; 10(9): 1218.
30.
SmitKFKonkelMKerindongoR, et al. Helium alters the cytoskeleton and decreases permeability in endothelial cells cultured in vitro through a pathway involving Caveolin-1. Sci Rep2018; 8(1): 4768.
31.
OeiGTHuhnRHeinenA, et al. Helium-induced cardioprotection of healthy and hypertensive rat myocardium in vivo. Eur J Pharmacol2012; 684(1–3): 125–131.
32.
WeberNCSchillingJMWarmbrunnMV, et al. Helium-induced changes in circulating caveolin in mice suggest a novel mechanism of cardiac protection. Int J Mol Sci2019; 20(11): 2640.
33.
GengTFengLFangYT, et al. Association between caveolin-1 and stroke: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci2020; 24(19): 10054–10060.
FuPChenFPanQ, et al. The different functions and clinical significances of caveolin-1 in human adenocarcinoma and squamous cell carcinoma. Onco Targets Ther2017; 10: 819–835.
36.
NwosuZCEbertMPDooleyS, et al. Caveolin-1 in the regulation of cell metabolism: a cancer perspective. Mol Cancer2016; 15(1): 71.
37.
DudãuMCodriciETanaseC, et al. Caveolae as potential Hijackable gates in cell communication. Front Cell Dev Biol2020; 8: 581732.
38.
SandvigKKavaliauskieneSSkotlandT. Clathrin-independent endocytosis: an increasing degree of complexity. Histochem Cell Biol2018; 150(2): 107–118.
39.
MadaioMPYanaseK. Cellular penetration and nuclear localization of anti-DNA antibodies: mechanisms, consequences, implications and applications. J Autoimmun1998; 11(5): 535–538.
40.
YanaseKMadaioMP. Nuclear localizing anti-DNA antibodies enter cells via caveoli and modulate expression of caveolin and p53. J Autoimmun2005; 24(2): 145–151.
41.
GolanTDSigalDSaboE, et al. The penetrating potential of autoantibodies into live cells in vitro coincides with the in vivo staining of epidermal nuclei. Lupus1997; 6(1): 18–26.
PolAMorales-PaytuvíFBoschM, et al. Non-caveolar caveolins - duties outside the caves. J Cell Sci2020; 133(9): jcs241562.
44.
XiaoZXOlsenNZhengSG. The essential role of costimulatory molecules in systemic lupus erythematosus. Lupus2019; 28(5): 575–582.
45.
JuryECKabouridisPS. T-lymphocyte signalling in systemic lupus erythematosus: a lipid raft perspective. Lupus2004; 13(6): 413–422.
46.
BorschukovaOPazZGhiranIC, et al. Complement fragment C3d is colocalized within the lipid rafts of T cells and promotes cytokine production. Lupus2012; 21(12): 1294–1304.
47.
DengGMTsokosGC. Cholera toxin B accelerates disease progression in lupus-prone mice by promoting lipid raft aggregation. J Immunol2008; 181(6): 4019–4026.
48.
VásquezABaenaAGonzálezLA, et al. Altered recruitment of Lyn, Syk and ZAP-70 into lipid rafts of activated B cells in Systemic Lupus Erythematosus. Cell Signal2019; 58: 9–19.
